[HTML][HTML] Time-trend of hospitalizations for anogenital warts in Veneto region in the HPV vaccination era: a cross sectional study (2007–2018)
S Cocchio, GM Prandi, P Furlan, C Bertoncello… - BMC Infectious …, 2020 - Springer
Background Human papillomavirus (HPV) is a common sexually transmitted pathogen and
the cause of several cancers and of anogenital warts. With this study, we estimated the trend …
the cause of several cancers and of anogenital warts. With this study, we estimated the trend …
High-risk human papillomavirus (HPV) infection and cervical cancer prevention in Britain: Evidence of differential uptake of interventions from a probability survey
C Tanton, K Soldan, S Beddows, CH Mercer… - … Biomarkers & Prevention, 2015 - AACR
Abstract Background: The third British National Survey of Sexual Attitudes and Lifestyles
(Natsal-3) provides an opportunity to explore high-risk human papillomavirus (HR-HPV) and …
(Natsal-3) provides an opportunity to explore high-risk human papillomavirus (HR-HPV) and …
Prevalence of anogenital warts among participants in private health plans in the United States, 2003–2010: potential impact of human papillomavirus vaccination
EW Flagg, R Schwartz… - American journal of …, 2013 - ajph.aphapublications.org
Objectives. We estimated anogenital wart prevalence from 2003 to 2010 by gender and age
group in a large US cohort with private insurance to detect potential decreases among …
group in a large US cohort with private insurance to detect potential decreases among …
[HTML][HTML] Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK
Background Human papillomavirus (HPV) is the most widespread sexually transmitted
infection worldwide. It causes several health consequences, in particular accounting for the …
infection worldwide. It causes several health consequences, in particular accounting for the …
[引用][C] The health and economic burden of HPV infection, genital warts, cervical dysplasia and cervical cancer in Canada
M Brisson, N Van De Velde, MC Boily, P De Wals - Can J Infect Dis Med Microbiol, 2006
[HTML][HTML] Testing previous model predictions against new data on human papillomavirus vaccination program outcomes
Background Vaccination against human papillomavirus (HPV), predominantly targeting
young females, has been introduced in many countries. Decisions to implement programs …
young females, has been introduced in many countries. Decisions to implement programs …
Assessing incidence and economic burden of genital warts with data from a US commercially insured population
T Hoy, PK Singhal, VJ Willey… - Current medical research …, 2009 - Taylor & Francis
Objective: This study examined the incidence of and healthcare costs attributable to genital
warts within a large US commercially insured, geographically dispersed population …
warts within a large US commercially insured, geographically dispersed population …
[HTML][HTML] Ethnic background and human papillomavirus vaccine uptake in Denmark: a countrywide retrospective cohort study including 274,154 women aged 19–28 …
VF de Casadevante, L Cantarero-Arévalo… - Papillomavirus …, 2016 - Elsevier
Aim We examined ethnicity-related differences in the uptake of a temporary free-of-charge
HPV vaccine (HPVV) catch-up programme offered in Denmark from August 2012 to …
HPV vaccine (HPVV) catch-up programme offered in Denmark from August 2012 to …
[HTML][HTML] Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global …
KM Abbas, K van Zandvoort, M Brisson… - The Lancet Global …, 2020 - thelancet.com
Summary Background The Papillomavirus Rapid Interface for Modelling and Economics
(PRIME) has been used around the world to assess the health impact and cost-effectiveness …
(PRIME) has been used around the world to assess the health impact and cost-effectiveness …
[HTML][HTML] The impact of HPV multi-cohort vaccination: real-world evidence of faster control of HPV-related morbidity
M Orumaa, SK Kjaer, C Dehlendorff, C Munk, AO Olsen… - Vaccine, 2020 - Elsevier
Abstract Background In 2009, both Norway and Denmark initiated routine quadrivalent
human papillomavirus vaccination (qHPV) for 12-year-old girls; however, Denmark also …
human papillomavirus vaccination (qHPV) for 12-year-old girls; however, Denmark also …